Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cannariginals is a California-based life sciences company specializing in the development of cannabis-infused therapeutic products for pain management and skin health. Founded in 2013, the company is recognized for its 'Emu 420 Essentials' product line, which utilizes a proprietary delivery system based on pure emu oil to facilitate the transdermal absorption of cannabinoids like CBD and THC. Their flagship products, including the 420 Gold Rub and Mystic Mango Medicated Elixir, are designed to provide localized and systemic relief for conditions such as chronic pain, inflammation, and various dermatological disorders. Cannariginals has received industry acclaim, including winning first place at the Medical Cannabis Cup, and maintains a significant retail presence in dispensaries throughout California.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cannariginals.